Janssen Inc. et al. v Pfizer Canada Inc. et al.

Call to arrange a consultation

2018

A-336-18

Resolved (Interlocutory)

Biosimilars

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Counsel to:

Pfizer Canada Inc., Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd. and Celltrion Inc.

The decision is reported

Partner

Associate